Achieve Life Sciences Inc (ACHV)
4.95
+0.26
(+5.54%)
USD |
NASDAQ |
Jun 21, 16:00
4.94
-0.01
(-0.20%)
After-Hours: 20:00
Achieve Life Sciences Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.007M |
| September 30, 2018 | 0.025M |
| June 30, 2018 | 0.124M |
| March 31, 2018 | 0.007M |
| December 31, 2017 | 0.009M |
| September 30, 2017 | 0.07M |
| June 30, 2017 | 0.241M |
| March 31, 2017 | 0.237M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.014M |
| September 30, 2015 | 0.013M |
| June 30, 2015 | 0.149M |
| April 30, 2015 | 12.31M |
| March 31, 2015 | 1.559M |
| January 31, 2015 | 11.21M |
| December 31, 2014 | 5.676M |
| Date | Value |
|---|---|
| October 31, 2014 | 11.67M |
| September 30, 2014 | 4.827M |
| July 31, 2014 | 14.43M |
| June 30, 2014 | 4.951M |
| April 30, 2014 | 9.862M |
| March 31, 2014 | 8.61M |
| January 31, 2014 | 11.59M |
| December 31, 2013 | 8.657M |
| October 31, 2013 | 17.65M |
| September 30, 2013 | 9.922M |
| July 31, 2013 | 15.91M |
| June 30, 2013 | 6.439M |
| April 30, 2013 | 16.54M |
| March 31, 2013 | 5.156M |
| January 31, 2013 | 15.43M |
| December 31, 2012 | 0.714M |
| October 31, 2012 | 26.16M |
| September 30, 2012 | 1.138M |
| July 31, 2012 | 16.13M |
| June 30, 2012 | 0.956M |
| March 31, 2012 | 0.774M |
| December 31, 2011 | 0.449M |
| September 30, 2011 | 0.987M |
| June 30, 2011 | 1.498M |
| March 31, 2011 | 1.348M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Accounts Receivable (Quarterly) Benchmarks
| Accelerate Diagnostics Inc | 2.217M |
| Atossa Therapeutics Inc | -- |
| ENDRA Life Sciences Inc | -- |
| Perspective Therapeutics Inc | 0.999M |
| Electromed Inc | 23.91M |